INTECH Investment Management’s Corcept Therapeutics CORT Stock Holding History

INTECH Investment Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.3M	Sell	37,992 -21,454	-36%	-$1.3M	0.03%	508
2026 Q1	$2.4M	Buy	59,446 +7,377	+14%	+$276K	0.02%	624
2025 Q4	$1.81M	Buy	52,069 +44,994	+636%	+$3.53M	0.02%	787
2025 Q3	$588K	Buy	+7,075	New	+$512K	0.01%	1486
2025 Q2	–	Sell	-66,735	Closed	-$7.62M	–	2500
2025 Q1	$7.62M	Buy	66,735 +14,628	+28%	+$890K	0.08%	224
2024 Q4	$2.63M	Buy	52,107 +31,575	+154%	+$1.65M	0.03%	566
2024 Q3	$950K	Buy	20,532 +6,140	+43%	+$218K	0.01%	844
2024 Q2	$468K	Buy	+14,392	New	+$394K	0.01%	825

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's CORT Position: Q2 2026 in Review

INTECH Investment Management reduced its Corcept Therapeutics (CORT) stake by 36% in Q2 2026, selling an estimated $1.3M and leaving 37,992 shares worth $3.3M. The position accounts for 0.03% of the portfolio, ranked #508.

INTECH Investment Management first reported a position in CORT in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.62M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

INTECH Investment Management held 37,992 shares of Corcept Therapeutics worth $3.3M as of Q2 2026.
INTECH Investment Management sold 21,454 Corcept Therapeutics shares in Q2 2026, an estimated $1.3M.
Corcept Therapeutics made up 0.03% of INTECH Investment Management's portfolio in Q2 2026, its #508 holding.
INTECH Investment Management first reported a position in Corcept Therapeutics in Q2 2024 and has held it in 8 quarters since.
INTECH Investment Management's Corcept Therapeutics position peaked at $7.62M in Q1 2025.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.